Ross L - Search Results

1

An Interim Report of the Scleroderma Clinical Trials Consortium Working Groups.

Baron M, Kahaleh B, Bernstein EJ, Chung L, Clements PJ, Denton C, Domsic RT, Ferdowsi N, Foeldvari I, Frech T, Gordon JK, Hudson M, Johnson SR, Khanna D, McMahan Z, Merkel PA, Narain S, Nikpour M, Pauling JD, Ross L, Valenzuela Vergara AM, Vacca A. Baron M, et al. Among authors: ross l. J Scleroderma Relat Disord. 2019 Feb;4(1):17-27. doi: 10.1177/2397198318783926. Epub 2018 Jul 18. J Scleroderma Relat Disord. 2019. PMID: 30906878 Free PMC article.

2

Rituximab treatment in primary angiitis of the central nervous system.

Patel S, Ross L, Oon S, Nikpour M. Patel S, et al. Among authors: ross l. Intern Med J. 2018 Jun;48(6):724-727. doi: 10.1111/imj.13814. Intern Med J. 2018. PMID: 29898271

3

Defining primary systemic sclerosis heart involvement: A scoping literature review.

Ross L, Prior D, Proudman S, Vacca A, Baron M, Nikpour M. Ross L, et al. Semin Arthritis Rheum. 2019 Apr;48(5):874-887. doi: 10.1016/j.semarthrit.2018.07.008. Epub 2018 Jul 31. Semin Arthritis Rheum. 2019. PMID: 30170705 Review.

4

The role of inflammatory markers in assessment of disease activity in systemic sclerosis.

Ross L, Stevens W, Rabusa C, Wilson M, Ferdowsi N, Walker J, Sahhar J, Ngian GS, Zochling J, Roddy J, Tymms K, Major G, Strickland G, Proudman SM, Nikpour M. Ross L, et al. Clin Exp Rheumatol. 2018 Jul-Aug;36 Suppl 113(4):126-134. Epub 2018 Sep 29. Clin Exp Rheumatol. 2018. PMID: 30277869

5

Constrictive pericarditis as the presenting manifestation of systemic sclerosis.

Patel S, Ross L, McKelvie P, Nikpour M. Patel S, et al. Among authors: ross l. Rheumatology (Oxford). 2019 Apr 1;58(4):732-734. doi: 10.1093/rheumatology/key404. Rheumatology (Oxford). 2019. PMID: 30590804 No abstract available.

6

Gaining the Upper Hand on Systemic Sclerosis Digital Ulcers.

Ross L, Nikpour M. Ross L, et al. J Rheumatol. 2019 Jun;46(6):548-549. doi: 10.3899/jrheum.180975. J Rheumatol. 2019. PMID: 31154442 No abstract available.

7

Can Patient-Reported Symptoms Be Used to Measure Disease Activity in Systemic Sclerosis?

Ross L, Stevens W, Wilson M, Strickland G, Walker J, Sahhar J, Ngian GS, Roddy J, Major G, Proudman S, Baron M, Nikpour M. Ross L, et al. Arthritis Care Res (Hoboken). 2020 Oct;72(10):1459-1465. doi: 10.1002/acr.24053. Arthritis Care Res (Hoboken). 2020. PMID: 31421031

8

Performance of the 2017 EUSTAR activity index in an scleroderma cohort.

Ross L, Stevens W, Wilson M, Huq M, Strickland G, Walker J, Sahhar J, Ngian GS, Roddy J, Youssef P, Proudman S, Nikpour M. Ross L, et al. Clin Rheumatol. 2020 Dec;39(12):3701-3705. doi: 10.1007/s10067-020-05126-z. Epub 2020 Jul 21. Clin Rheumatol. 2020. PMID: 32696281

9

Are troponin and B-type natriuretic peptides useful biomarkers for the diagnosis of systemic sclerosis heart involvement? A systematic literature review.

Ross L, Moxey J, Nikpour M. Ross L, et al. Semin Arthritis Rheum. 2021 Feb;51(1):299-309. doi: 10.1016/j.semarthrit.2020.10.016. Epub 2020 Dec 29. Semin Arthritis Rheum. 2021. PMID: 33434765 Review.

10

Sudden Cardiac Death in Systemic Sclerosis: Diagnostics to Assess Risk and Inform Management.

Ross L, Paratz E, Baron M, La Gerche A, Nikpour M. Ross L, et al. Diagnostics (Basel). 2021 Sep 28;11(10):1781. doi: 10.3390/diagnostics11101781. Diagnostics (Basel). 2021. PMID: 34679479 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,990 results

Search Page